Although the number of studies is small, anti-fibrillarin has been associated with dcSSc and multi-organ involvement (9, 19), with high risk of cardiac involvement, ILD, PAH, renal crisis, small bowel and muscle involvement. Here, FBL is linked to interstitial lung disease.